tiprankstipranks
AEON Biopharma (AEON)
NYSE MKT:AEON
US Market
Holding AEON?
Track your performance easily

AEON Biopharma (AEON) Financial Statements

92 Followers

AEON Biopharma Financial Overview

AEON Biopharma's market cap is currently ―. The company's EPS TTM is $-0.241; its P/E ratio is -2.20; AEON Biopharma is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Mar 24Sep 23Dec 22Sep 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -6.17M$ -31.25M$ 43.88M$ 4.33M$ -10.44M
EBITDA$ -6.17M$ -31.22M$ 43.88M$ 4.33M$ -10.40M
Net Income Common Stockholders$ -6.17M$ -31.25M$ 22.63M$ -46.76M$ -10.44M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 500.00K$ 1.56M$ 16.20M$ 67.91K$ 27.76K
Total Assets$ 4.00M$ 3.03M$ 17.62M$ 279.49M$ 277.32M
Total Debt$ 16.37M$ 5.09M$ 52.00K$ 0.00$ 0.00
Net Debt$ 15.87M$ 3.53M$ -16.15M$ -67.91K$ -27.76K
Total Liabilities$ 36.09M$ 201.41M$ 139.36M$ 10.44M$ 11.97M
Stockholders Equity$ -30.27M$ -186.36M$ -121.74M$ -9.44M$ -11.55M
Cash Flow-
Free Cash Flow-$ -8.60M$ -15.06M$ -170.28K$ -26.86M
Operating Cash Flow$ -2.96M$ -8.60M$ -15.06M$ -170.28K$ -26.56M
Investing Cash Flow---$ 60.42K$ -377.50K
Financing Cash Flow$ 50.00K$ 5.00M-$ 150.00K$ 44.50M
Currency in USD

AEON Biopharma Earnings and Revenue History

AEON Biopharma Debt to Assets

AEON Biopharma Cash Flow

AEON Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis